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differentiation stage-specific protein distribution
Congdi Song1, Yana Feodorova1, Jacky Guy2, Leo Peichl3, Katharina Laurence Jost4, Hiroshi Kimura5,
Maria Cristina Cardoso4, Adrian Bird2, Heinrich Leonhardt1, Boris Joffe1ˆ and Irina Solovei1*Abstract
Background: Methyl-CpG binding protein 2 (MECP2) is a protein that specifically binds methylated DNA, thus
regulating transcription and chromatin organization. Mutations in the gene have been identified as the principal
cause of Rett syndrome, a severe neurological disorder. Although the role of MECP2 has been extensively studied
in nervous tissues, still very little is known about its function and cell type specific distribution in other tissues.
Results: Using immunostaining on tissue cryosections, we characterized the distribution of MECP2 in 60 cell types
of 16 mouse neuronal and non-neuronal tissues. We show that MECP2 is expressed at a very high level in all retinal
neurons except rod photoreceptors. The onset of its expression during retina development coincides with massive
synapse formation. In contrast to astroglia, retinal microglial cells lack MECP2, similar to microglia in the brain,
cerebellum, and spinal cord. MECP2 is also present in almost all non-neural cell types, with the exception of intestinal
epithelial cells, erythropoietic cells, and hair matrix keratinocytes. Our study demonstrates the role of MECP2 as a
marker of the differentiated state in all studied cells other than oocytes and spermatogenic cells. MECP2-deficient
male (Mecp2−/y) mice show no apparent defects in the morphology and development of the retina. The nuclear
architecture of retinal neurons is also unaffected as the degree of chromocenter fusion and the distribution of major
histone modifications do not differ between Mecp2−/y and Mecp2wt mice. Surprisingly, the absence of MECP2 is not
compensated by other methyl-CpG binding proteins. On the contrary, their mRNA levels were downregulated in
Mecp2−/y mice.
Conclusions: MECP2 is almost universally expressed in all studied cell types with few exceptions, including microglia.
MECP2 deficiency does not change the nuclear architecture and epigenetic landscape of retinal cells despite the
missing compensatory expression of other methyl-CpG binding proteins. Furthermore, retinal development and
morphology are also preserved in Mecp2-null mice. Our study reveals the significance of MECP2 function in cell
differentiation and sets the basis for future investigations in this direction.
Keywords: MECP2, MBD, Histone modifications, Nuclear architecture, Mouse retina, Retina development, Mouse tissuesBackground
Methyl-CpG binding protein 2 (MECP2) was discovered
as a protein that selectively binds methylated DNA [1].
Mutations of the MECP2 gene were later identified as
the principal causative factor for Rett syndrome, a
severe progressive neurological disorder affecting almost
exclusively females [2]. Mild loss of function mutations,* Correspondence: Irina.Solovei@lrz.uni-muenchen.de
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unless otherwise stated.duplications, and expression level alterations has also
been found in patients with a plethora of neurological
and mental phenotypes [3-6]. In mice, deletion of the
Mecp2 gene causes symptoms similar to those of Rett
syndrome even when the deletion is restricted to the
brain [7-10], while expression of Mecp2 rescues the
Rett phenotype. More effective rescue was achieved
through embryonic, compared to early postnatal expression
[11-13], whereas targeted expression in postmitotic neurons
resulted in asymptomatic mice [12,14]. Mecp2 mutant mice
exhibit abnormalities in the number of synapses [15], the
morphology of neuronal processes [16,17], neuronal matur-
ation [16], and the neurophysiological activity of these cellstd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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types. For instance, brain stem GABA-ergic neurons are
affected, but glycinergic ones are not [20]. Glutamatergic
neurons of the brain and their synapses are also affected
through the expression level of brain-derived neurotrophic
factor (BDNF) [21] which is regulated by MECP2 in a
neuronal activity-dependent manner [17,22,23].
The results listed above conform to the conclusion that
MECP2 deficiency leads to subtle changes in the expression
levels of genes causing diverse and widespread phenotypic
changes [24]. There is growing evidence that both Mecp2-
null astrocytes [25] and microglia [26] affect the dendritic
morphology of neurons. Lack of MECP2 causes global
histone H3 hyperacetylation in neurons [10,27], which
can have different effects on transcription depending on
which lysine residues are acetylated. It remains, however,
unknown if global histone H3 acetylation levels increase
exclusively in neurons or also take place in glia [10,21,27].
Factual data about the phenotypic changes in various
tissues of Mecp2-null mice are currently insufficient and
partially controversial.
In addition to its role in transcriptional regulation,
MECP2 appears to be important for maintenance of the
general chromatin organization. Mecp2-null brain shows
a ca. 1.6-fold upregulation in spurious transcription of
repetitive DNA, in particular L1 retrotransposons and
pericentromeric satellites [27], which have been impli-
cated in maintenance of the nuclear architecture and its
formation during cell differentiation [28-30]. In all mouse
cells, subcentromeric repetitive blocks, composed of
major satellite repeat, form spherical bodies, so called
chromocenters that are predominantly located at the nu-
clear periphery and adjacent to the nucleolus. Remarkably,
mouse chromocenters are extremely enriched in MECP2
[1] and the same applies to clusters of human alphoid sat-
ellites, also often called chromocenters. There is growing
evidence that DNA methylation and MECP2 binding to
methylated DNA are pivotal for chromocenter formation
and, therefore, the establishment of normal nuclear archi-
tecture [31-35]. MECP2 indeed seems to be required
for chromocenter fusion during differentiation [8,32,36],
although other methyl binding (MBD) proteins can com-
pensate for its absence [31,33,35].
In order to provide better understanding of MECP2
function, we characterized the distribution of the protein
in more than 60 cell types of 16 mouse neuronal and
non-neuronal tissues by immunostaining. We show that
MECP2 is expressed at a very high level in all retinal
neurons except rod photoreceptors. The onset of its
expression during retina development coincides with
massive formation of the neural synapses. We also describe
the distribution of MECP2 in other tissues at various stages
of development and relate its increased expression to the
terminal differentiation of cells. Mice lacking MECP2 showno apparent defects in the morphology and development of
the retina, as well as in the nuclear architecture of retinal
neurons. Finally, we show that the absence of MECP2 is
not compensated by upregulation of other MBD proteins
but rather causes their downregulation.Results and discussion
We studied mouse tissues because the nuclei of all mouse
cells have prominent chromocenters which are convenient
for the microscopic approach. The main DNA sequence
of chromocenters, major satellite repeat, is present on
all autosomes, comprises ca. 10% of whole mouse DNA,
contains ca. 50% of the CpG dinucleotides of the whole
mouse genome [37], and was shown to bind MECP2 [1].
Therefore, chromocenters can serve as a sensitive indica-
tor of MECP2 expression after immunostaining. To avoid
interpretations which might depend only on chromocen-
ters, in all relevant cases, we also studied rat tissues. In
contrast to mouse, rat chromosomes do not have large
blocks of pericentromeric repeats and therefore do not
form noticeable chromocenters in interphase nuclei.
The standard methods of protein-level estimation, such
as Western blot analysis routinely used for homogeneous
cell cultures, are not really useful for native tissues con-
taining various cell types. Therefore, our method of choice
was MECP2 immunostaining on cryosections where we
could distinguish different cell types using either histo-
logical criteria or cell-specific antibodies (Tables 1 and 2).
To avoid false-positive and false-negative results after
antibody staining, we used a robust and reliable method
developed by us earlier [38,39]. This method allows quick
comparison of immunostaining results in the same tissue
after various fixation and antigen retrieval times. Polyclonal
anti-MeCP2 antibodies, mostly used in the study, do
not produce nuclear staining in fibroblasts derived from
MECP2-deficient mice (Additional file 1A) and, when
applied to Western blot, show expected enrichment of
the protein in brain tissue derived from wild-type (WT)
mice (Additional file 1B).MECP2 in retinal cell types
The retina is an attractive model to study the role of
MECP2 in a nerve center. Most of the retinal cell types
can be recognized by their positions and by the shape of
their nuclei; only in a few cases, identification requires
cell type-specific immunostaining. Most of the mouse
retinal cells express MECP2: their nuclei possess a weak
or moderate staining of the nucleoplasm and a strong
signal in chromocenters. In particular, all neurons in the
ganglion cell layer (GCL), inner nuclear layer (INL), and
cone photoreceptors in the outer nuclear layer (ONL) have
very strong chromocenter staining and a weak nucleoplasm
staining (Figure 1A).
Table 1 List of antibodies for cell type identification in retina and brain and for recognition of retinal structures
Antibody abbreviation Antigen transmitter/protein Recognized cells/structures Source, catalogue number
ChAT Choline acetyl transferase Cholinergic amacrine cells Millipore, AB144P
Calbindin Calcium-binding protein 28 kD Horizontal cells SWANT, #300
GFAP Glial fibrillary acidic protein Astroglia Sigma, G 3893
GABA Gamma aminobutyric acid Amacrine, horizontal cells Sigma, A 2052
GABA-A α1 GABA receptor subunit α1 Bipolar, amacrine, and ganglion
cell processes in IPL
Millipore, #06-868
GABA-C GABA receptor subunit ρ1 Synapses in IPL R. Enz, MPI for Brain Research, Frankfurt
GAT GABA transporter Presynaptic terminals Abcam, ab426
GAD-65 Glutamic acid decarboxylase
(GABA-synthesizing enzyme)
Amacrine, horizontal cells Chemicon, MAB351R
GAD-67 Glutamic acid decarboxylase
(GABA-synthesizing enzyme)
Amacrine, horizontal cells Abcam, ab26116
GS Glutamine synthetase Müller cells (astroglia) BD Biosciences, #610517
GluR3 Glutamate-gated ion channel
(glutamate receptor 3)
Synapses in IPL and OPL Santa Cruz, sc-7612
GlyT1 Glycine transporter 1 Amacrine cells Chemicon, AB1770
Iba 1 Ionized calcium binding adaptor
molecule 1
Microglia/macrophage Wako, #019-19741
MAP2 Microtubule-associated protein 2 Neurons Sigma, M1406
NR1C2 NMDA receptor 1 splice variant C2 IPL and OPL synapses Chemicon, AB5050P
PKCα Protein kinase C Rod bipolar cells Sigma, P 4334
PKA II β Human protein kinase A, regulatory
subunit II beta
Cone bipolar cells BD Biosciences, #54720
PSD-95 Postsynaptic density protein 95 Photoreceptors (rods and cones)
synapse marker
Dianova, MA1-046
SV2 Membrane of synaptic vesicles General synapse marker DSHB, SV2-a1
TH Tyrosine hydroxylase Dopaminergic amacrine cells Immunostar, #22941
VGLUT1 Vesicular glutamate transporter 1 IPL and OPL synapses Millipore, MAB5502
VGLUT3 Vesicular glutamate transporter 3 Amacrine cells Millipore, AB5421
Znp-1 (Syt2) Synaptotagmin II Cone bipolar cells Zebrafish International Resource Center,
University of Oregon, Eugene, OR, Znp-1
Millipore (Billerica, MA, USA), Swant (Marly, Switzerland), Sigma-Aldrich (St. Louis, MO, USA), Abcam (Cambridge, UK), Chemicon (Billerica, USA), BD Biosciences
(Franklin Lakes, NJ, USA), Santa Cruz (Dallas, TX, USA), Wako (Richmond, VA, USA), Dianova (Hamburg, Germany), DSHB (University of Iowa, IA, USA).
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nuclei of nocturnal mammals possess a dramatically dif-
ferent pattern of chromatin distribution [30]. In these
cells, a centrally positioned chromocenter is surrounded
by a shell of LINE-rich heterochromatin, whereasTable 2 List of antibodies for cell type identification in
tissues other than the retina
Cell type Protein Source, catalogue number
Smooth muscles Calponin Abcam, ab46794
Paneth cells Lysozyme Dako, A 0099
Enteroendocrine cells Secretin Santa Cruz, sc-26630
Goblet cells Mucin-2 Santa Cruz, sc-15334
Satellite cells Pax 7 DSHB
Dako (Troy, MI, USA).euchromatin occupies the nuclear periphery. This nu-
clear organization is inverted in comparison to all other
eukaryotic cells possessing conventional nuclear architec-
ture with heterochromatin abutting the nuclear periphery
and euchromatin located in the nuclear interior [28,30].
We have shown that the inverted nuclear architecture
in rods has evolved as an adaptation to nocturnal vision:
the heterochromatic cores of rod nuclei function as
microlenses and reduce light scatter in ONL [30]. Un-
expectedly, the nucleoplasm of the inverted rod nuclei is
not stained by anti-MECP2 antibodies, and the central
chromocenter is only weakly positive (Figure 1A).
In comparison to the multiple chromocenters character-
istic of other mouse cell types, the single central chromo-
center in mouse rods has a superior chromatin density,
which is necessary for rod nuclei to function as microlenses
Figure 1 Distribution of MECP2 in the nuclei of retinal cells. (A) MECP2 is abundant in all retinal neurons: in the ganglion cell layer (GCL),
inner nuclear cell layer (INL), in bipolar (BC) and amacrine (AC) cells. The signal is present throughout the whole nucleoplasm but is especially
strong in chromocenters. In the ONL of adult mice, MECP2 produces a strong signal in cone photoreceptors (CP) whereas rod photoreceptors
(RP) have very weak staining only noticeable in the chromocenters (arrowheads). (B) Restoration of conventional nuclear architecture in rod nuclei by
Lbr expression in Lbr-TER mice does not increase MECP2 expression. In Lbr-expressing rods (three such nuclei are marked by empty arrowheads), there
are multiple chromocenters adjacent to the nuclear periphery. These chromocenters (arrows) remain weakly MECP2-positive and with the staining
intensity comparable to that of chromocenters in inverted nuclei not expressing Lbr. For comparison, bright staining of cone nuclei (empty arrows, left
and middle upper panels) is shown. Note that all rods with multiple chromocenters adjacent to the nuclear periphery express Lbr (Solovei et al. [41]);
LBR staining is not shown on this panel. (C) In R7E mice, rods de-differentiate, partially restore the conventional architecture of their nuclei, and lose their
rod identity. This process is accompanied by increased expression of MECP2 which becomes abundant in chromocenters (three such nuclei are marked
by arrowheads) and reaches the same level as in neuroretina (upper panel). For comparison, an unaltered rod nucleus is marked (arrow). (D) Retina of rat
(D1) and macaque (D2). Similarly to mice, MECP2 produces a bright signal in the GCL, INL, and cones (arrowheads) but is weak to undetectable in rod
cells (arrows). Single confocal sections. Scale bars: (A) 10 μm; (B) 5 μm; (C) overview 25 μm, rods 5 μm; (D) overviews 50 μm, ONLs 10 μm.
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recent electron microscopic studies (e.g., Figure two in [38]
and Figure three panel a in [40]) and from the dramatic
difference in immunostaining properties between rod
chromocenters and chromocenters of other retinal neurons.
As described in detail in the recent immunohistochemical
studies [38-40], the chromocenter in rods requires much
longer antigen retrieval in comparison to the neighboring
cones and INL cells. Therefore, to rule out that weak
MECP2 staining is caused by inaccessibility of chromocen-
ter chromatin to the antibodies, we made use of transgenicmouse retinas in which rod cells ectopically express lamin
B receptor (LBR). Rods expressing transgenic LBR acquire
conventional nuclear architecture with euchromatin located
to the nuclear interior and heterochromatin, including
multiple chromocenters, located at the nuclear periphery.
Chromocenters of these transgenic rods have apparently
lower chromatin compaction and restore immunostaining
ability typical for other retinal cells [41]. However, despite
their reduced size and density, chromocenters in LBR-
expressing rods remain as weakly MECP2-positive as the
chromocenters of wild-type rods (Figure 1B).
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of MECP2 staining in photoreceptors of R7E mice
[42]. These transgenic mice specifically express CAG
trinucleotide repeat encoding a polyglutamine stretch
and represent a mouse model to study spinocerebellar
ataxia type 7 (SCA7). In R7E mice, mature rods with
inverted nuclei begin to de-differentiate in ca. 1-month-
old animals, their nuclei partially restore a conventional
nuclear architecture, and photoreceptors lose their rod
identity [42]. MECP2 expression in R7E rods gradually
increases in parallel to the de-differentiation, and at the
age of 20 weeks, the MECP2 level in chromocenters
reaches the level observed in the other neurons of the
retina (Figure 1C).
Furthermore, we also tested for the presence of MECP2
in rods of two other mammalian species: (i) rat, a noctur-
nal mammal without chromocenters; and (ii) macaque, a
diurnal primate with conventional nuclear architecture in
rods. In both species, MECP2 was undetectable in rods, in
a prominent difference to neuroretinal cells and cone pho-
toreceptors where it produced a clear signal (Figure 1D).
Taken together, the above data imply that weak expression
of MECP2 is an intrinsic feature of rod photoreceptors.
The low level of MECP2 in rods can be tentatively
connected to the relatively high level of linker histone
H1c in rod cells described recently for mouse rod photo-
receptors [43]. It has been shown that in the MECP2-rich
neurons of the brain, approximately half of the linker
histone H1 tends to be replaced by MECP2, and that in
Mecp2-null mice, the H1 level in these neurons doubles
[27]. Remarkably, triple KO mice deficient in linker
H1c/H1e/H10 histone variants show significant increase
of the rod nuclear diameter which was accompanied by
decrease of the nuclear volume occupied by heterochro-
matin. These changes in the nuclear architecture were
noticed only in rod nuclei [40]. The other way around,
in de-differentiated rods of R7E mice, which demonstrate
significantly reduced level of H1c [44,45], the expression
of MECP2 increases (Figure 1C).
Microglial cells have no detectable MECP2
Non-neuronal cells of the retina—pigment epithelium,
endothelial cells of blood vessels, and Müller cells (radial
astroglia)—also expressed MECP2. The only exception
was microglia where MECP2 was never detected by im-
munostaining (Figure 2A). Moreover, microglial cells,
identified using anti-lba1 antibodies, were negative for
MECP2 staining not only in the retina but also in the
brain, cerebellum and spinal cord (Figure 2A). In contrast,
in astroglial cells (Figure 2B) and neurons (Figure 2C1,
C2), nuclei are strongly positive after MECP2 staining.
Absence of MECP2 in microglial cells revealed by immu-
nostaining is especially intriguing in view of recent
data on the involvement of microglial cells in the Rettphenotype [46] and questions the role of these cells in
neuropathologic consequences of MECP2 deficiency.
On the other hand, sensitivity of immunostaining is
unquestionably lower than most of biochemical in vitro
approaches, and therefore, one cannot wholly exclude that
microglia cells express MECP2 at a level not detectable
microscopically.
Retinas of Mecp2-null mice show no apparent defects
Absence of MECP2 impairs neuronal morphology and
strongly affects functions of the brain [9]. The retina, as
a compact and very regularly structured part of the CNS,
represents an attractive model to study the possible effects
of MECP2 on the nervous system development. Earlier, it
was shown that in Mecp2 knockout mice, decline in visual
acuity, which was observed in late postnatal development,
is caused by general silencing of the cortical circuitry [47].
However, major morphological characteristics of retinas in
MECP2-deficient mice have not been yet reported. We
dissected retinas of Mecp2−/y mice at different stages of
retina maturation, at postnatal days P1, P7, P13, P30,
and P53, and compared their histology to the retinas of
wild-type littermates. We found that Mecp2−/y and WT
retinas were not different with respect to the time of
layer formation, thickness, and morphology of the layers
at all five studied developmental stages (Additional file 2).
In addition, we compared Mecp2−/y and Mecp2wt retinas
with respect to the distribution of various retinal markers.
Twelve immunocytochemical markers specific for various
amacrine, bipolar, ganglion, and horizontal cells, seven
markers for inner plexiform layer (IPL) or/and outer plexi-
form layer (OPL), and markers for radial glia (Müller cells)
and microglia (Table 1) were applied to retinas from adult
Mecp2−/y and WT littermate mice. As shown in Figure 3A
and Additional file 3, no noticeable differences in the
distribution of certain neurons, synapses, and neuro-
transmitters were found between the two genotypes.
Nuclear architecture of neuronal nuclei in Mecp2-null
mice is generally preserved
Since MECP2 is a methylation reader and apparently
involved in heterochromatin formation [27,36], we checked
whether its absence causes changes in the epigenetic land-
scape of rod and other retinal nuclei. We found that
MECP2 deficiency did not have any microscopically visible
effect on the presence and distribution of major histone
modifications (Table 3). In Mecp2−/y mice, euchromatin
marked by acetylated H3, H4, H3K9ac,me1, and H4K20ac,
me1 was present in the nuclear interior of GCL and INL
cells and in the outermost peripheral shell of rod nuclei,
just as it was observed in WT mice (Figure 3B, Additional
file 4). The presence of histone modifications H3K9me2,3
and H4K20me2,3, characteristic of heterochromatin, was
restricted to the nuclear periphery and chromocenters
Figure 2 Microglial cells (A) have no detectable MECP2 compared to astroglia (B) and neurons (C). (A, B) MECP2 detection in brain cortex,
cerebellum, spinal cord, and retina combined with microglial (A) and astroglial (B) cell type-specific staining. Overlays of 4',6-diamidino-2-phenylindole
(DAPI) staining (red) with markers for microglia (Iba-1) and astroglia (GFAP) are shown in left columns as projections of short stacks. Middle and right
columns show single optical sections (zoomed in) for DAPI and MECP2. Non-marked cells in the same images are predominantly neurons and strongly
express MECP2. Red outlines in the right column images trace the shape of the nuclei of interest. (C) Neurons from cerebellum – Purkinje cells (C1) and
granular cells (C2) demonstrate strong MECP2 staining in chromocenters and moderate staining of the nucleoplasm in a single confocal section. Scale
bars: (A,B) 10 μm, (C) 5 μm.
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wild-type (Additional file 4; see also [38]).
Conversely, we checked whether erasing of the major
heterochromatin hallmarks, H3K9me2,3 and H4K20me3,
would prevent MECP2 binding. For this purpose, we stud-
ied retinas from mice lacking H4K20me3 due to deletion
of Suv4-20 h2 and mice lacking both H4K20me3 and
H3K9me3 due to deletion of Suv4-20 and Suv3-9 h1,2
methyltransferases. In mice of both genotypes, rod nuclei
had the same morphology as the rod nuclei in the wild-
type littermate controls [38]. We found that the pattern
of MECP2 staining was not different between the retinal
cells in the wild-type and knockout mice, suggesting
that MECP2 binding to chromatin was not affected. In-
deed, MECP2 was strongly expressed in neuroretina
and cones, where it localizes mostly in chromocenters,
and was almost undetectable in rods (Additional file 5).
Recently, it was shown that deletion of Suv4-20 h2 influ-
ences chromatin organization in cultured cells, in particular,
it increases the number of chromocenters in cultured fibro-
blasts derived from a Suv3-9/Suv4-20 h double knockoutmouse [48]. In contrast, double knockout of Suv3-9 and
Suv4-20 affects neither rod nuclear morphology [38] nor
MECP2 binding patterns (this study), suggesting that cells
in a tissue context might have more redundancy in epigen-
etic mechanisms than cultured cells.
Although even a complete loss of MECP2 does not
prevent chromocenter formation in mouse cells [8],
observations on astroglial cells and neurons differenti-
ated from embryonic stem cells in vitro showed that
the number of chromocenters was significantly higher
in MECP2-null cells compared to wild-type cells [36].
The other way around, ectopic expression of MECP2
induces clustering and fusion of chromocenters, a
process which takes place during myotube differentiation
[31]. These findings prompted us to assess rod chromo-
center numbers in adult mice of both genotypes. Chro-
mocenter fusion in nuclei of mouse rods is a slow
process. A significant proportion of rods at ca. 1 month
still have two or more chromocenters; their fusion in
all rods is completed only at 2–2.5 months of age
([30,41]; c.f. Figure 3C2,C3). We scored cells with one
Figure 3 Retinas of Mecp2−/y mice show no apparent defects. (A) Positioning of amacrine cells, rod bipolar cells, and photoreceptor synapses
is similar in retinas of Mecp2−/y and Mecp2lox/y littermates. Other 14 markers for retinal cell types, synapses, and neurotransmitters are shown in
Additional file 2. (B) Similar distribution of a histone modification typical of euchromatin (H3ac) in Mecp2−/y and Mecp2wt littermate retinas; nuclei with
conventional (ganglion and INL cells) and inverted (rods) architecture are shown. (C) The proportions of rod nuclei with two or more chromocenters
were scored in retinas of two Mecp2−/y and one Mecp2wt littermate at two age points, P30 and P53 (C1). At P53, nearly all nuclei have a single
chromocenter. Average proportions of rods with two or less chromocenters were not significantly different between the two genotypes. Errors bars
are the 95% confidence intervals. Rod nuclei with two (C2) and one (C3) chromocenter. Scale bars: (A) 25 μm, (B) 5 μm, (C) 2 μm.
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mice and their wild-type littermates at P30 and P53
(see the ‘Methods’ section for detailed description).
The number of rods with two or more chromocenters
in Mecp2−/y mice of these ages was 15.5% at P30 and
1.2% at P53, which was not different from the wild-
type (Figure 3C1).
In full agreement with our observations on rod cells,
data obtained from cortical neurons in tissue sections and
primary neuronal cultures indicate that chromocenter num-
ber is comparable between neurons from Mecp2−/y and
Mecp2+/y mice [35]. Apparently, the difference in results ob-
tained on cells in native tissues of Mecp2−/y and Mecp2+/y
mice and on cultured cells derived from these mice [36] isanalogous to the observations on Suv3-9/Suv4-20 h double
knockout cells and might be tentatively explained by com-
pensatory mechanisms operating in vivo but not in vitro.
Almost all cell types in adult mammalian tissues express
MECP2
The absence of MECP2 in microglia and its low level in
rods raised the question of how common MECP2 is in
various cell types. Data on MECP2 expression in different
tissues are limited, and most reports are based on a
bulk analysis of protein or RNA extracted from a whole
tissue (e.g., [49,50]). Analyses of specific cell types are only
occasional and predominantly concern neuronal tissues
[49-51]. Therefore, we studied MECP2 distribution across
Table 3 List of antibodies for histone modification detection
Histone/residue Modification Source (catalogue number)
H3K9 Acetyl HK (CMA310)
Me1 HK (CMA316)
Me2 HK (CMA317)
Me3 HK (CMA318)
H4K20 Acetyl HK (CMA420)
Me1 HK (CMA421)
Me2 HK (CMA422)
Me3 HK (CMA423)
H3 Acetyl Upstate (#06-599)
H4 Acetyl Upstate (#06-866)
HK produced in the laboratory of Hiroshi Kimura, Osaka University (Osaka,
Japan). Upstate (Lake Placid, NY, USA).
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based either on histological criteria or, when needed,
on cell type-specific immunostaining (for the list of
antibodies used, see Table 2). Altogether, about 60 cell
types were studied from 12 non-neuronal adult mouse
tissues. In addition, epidermis and skeletal muscles were
studied at five age points (P0, P2, P5, P9, and P14). The
results of immunostaining are summarized in Figure 4A,
and telling examples are shown in Figure 4B,C,D,E,F,G,H.
We found that the majority of cell types express MECP2;
those that do not are rather a minority. MECP2 is lacking
in epithelial cells of the intestine and colon. In epidermis,
the expression of MECP2 varies: it is absent or present at
a hardly detectable level in keratinocytes of the trunk skin
but is more abundant in lip epidermis cells, both basal
and suprabasal. In the hair, proliferating matrix keratino-
cytes of the hair bulb lack MECP2 in clear difference to
differentiated keratinocytes of hair shaft and hair root
sheath where MECP2 produces a clear signal. MECP2
is also not expressed in the erythropoietic lineage, in
contrast to other cells of the myeloid lineage and lympho-
cytes. A noteworthy exception are resident macrophages.
As mentioned before, microglial cells in all studied ner-
vous tissues do not express MECP2 at a detectable level
(Figures 2A and 4A), whereas resident macrophages from
other tissues, in particular, hepatic Kupffer cells, do
express it (Figure 4A,H).
As MECP2 is primarily visible in the chromocenters of
mouse cells, we studied MECP2 distribution in tissues of
a species, which does not possess chromocenters in inter-
phase nuclei. Rat chromosomes, in difference to mouse
chromosomes, lack large blocks of pericentromeric satel-
lite sequences, and consequently, rat nuclei have no clear
chromocenters. Rat small intestine, skin with hairs, and
skeletal and heart muscles were studied. Staining of these
tissues confirmed that the gastrodermal epithelial and hair
matrix cells in rat, similarly to mouse, lack MECP2,whereas the nuclei of muscle cells (smooth, skeletal, and
heart muscles) had a strong punctate MECP2 signal in the
nucleoplasm (Figure 5). Our data support the notion that
in addition to the functions in the nervous system that are
associated with a major pathologic phenotype, MECP2
plays some important roles in almost all non-nervous
tissues.
Involvement of MECP2 in chromatin regulation and
maintenance of global nuclear architecture is well docu-
mented [27,52,53]. In particular, it is known that MECP2
plays a role in the regulation of transcription, being
mostly a transcriptional repressor [54-56] and also an
activator [54]. In the light of these findings, the fact that
some cell types across different species are lacking MECP2
is intriguing and requires further analysis.
Expression of MECP2 increases during tissue
development and terminal cell differentiation
There is a clear difference between MECP2 expression
levels in tissues of different developmental stages. A tell-
ing example are fibroblasts of the dermal papilla in the
hair bulb. These cells lack MECP2 at the late embryonic
stages and in the first 2 days of postnatal development;
the expression starts at P2 and continues afterwards
(Figure 6D).
The expression of MECP2 in the retina starts at different
times depending on the cell type. Remarkably, the onset of
expression coincides with massive formation of synapses
and, as a consequence, the formation of the IPL and OPL
[57-59] (Figure 6A,B). In particular, MECP2 appears in
the ganglion and amacrine cells at E17, when a clear
gap appears between the GCL and INL + ONL anlage,
marking the emerging IPL. Similarly, the MECP2 expres-
sion in the bipolar cells starts at P6 together with the
formation of the gap between the INL and ONL, which
develops into the OPL later. In rods, weak MECP2 expres-
sion starts after 2 weeks of postnatal development and
remains weak thereafter (Figure 6A,C). Noteworthy, the
onset of MECP2 expression roughly correlates with cell
birthdays (the day of the last cell division; [60]) of the
retinal neuronal cell types (RSpearman = 0.62) and persists
afterwards.
Initiation of MECP2 expression at late differentiation
stages proved to be a general rule: undifferentiated or
weakly differentiated cells (progenitors) do not express
MECP2 or show a low expression level compared to the
respective fully differentiated cells. In particular, matrix
keratinocytes of the hair bulb do not express MECP2,
the more differentiated keratinocytes of the hair shaft
show a weak expression, and a stronger expression is ob-
served in the keratinocytes at the root hair shaft. MECP2
is weak in satellite cells but abundant in the myotube nu-
clei (Figure 4A,F). The reverse situation occurs only in the
gonads. In the ovaries, the follicle epithelium and the
Figure 4 Presence of MECP2 in different cell types of adult mouse tissues. (A) List of the studied tissues and cell types; the strength of
MECP2 signal is shown by the number of plus signs (1 to 3). *Tissues studied at six developmental age points (P0, P2, P5, P9, and P14). **Satellite cells
were negative at P0–P14. ***Dermal fibroblasts were negative at P0–P5. ****Fibroblasts of dermal papilla were negative at P0 and weakly positive at
P2; see also Figure 5D. Examples of mouse tissues after MECP2 staining: intestine (B, C), hair (D), muscles (E, F, G), and liver (H). In (C), empty arrows
point at MECP2-negative gastroepithelial cells in colon crypt; empty arrowheads point at positive smooth muscle nucleus beneath the gastrodermis. In
(D), solid arrows mark fibroblasts of the dermal papilla; solid arrowheads mark matrix keratinocytes of the hair bulb. For comparison of MECP2 staining
in mouse and rat tissues, see Additional file 4. Single confocal sections. Scale bars: (B) 50 μm, (C, D) 10 μm, (E, F, G, H) 5 μm.
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do not (Figure 7A). Sertoli cells and fibroblasts are MECP2
positive, whereas spermatogenic cells do not express
MECP2 at any stage (Figure 7B). The absence of MECP2
immunostaining in mature gametes conforms to the known
fact that zygotes, stem cells, and cells of young embryos
[61-63] lack MECP2. In summary, our results indicate that
MECP2 is a marker of the differentiated state.Absence of MECP2 is not compensated by altered
expression of other MBD proteins in cultured cells and
native tissues
Considering the specific binding of MECP2 to methyl-
ated DNA, we questioned whether other proteins are
able to replace MECP2 on 5-methylcytosine (5mC) in case
of its absence. Though this has not been systematically
investigated, the question has been addressed genetically
Figure 5 Comparison of MECP2 staining in selected mouse and rat tissues. Nuclei of striated muscle cells (A, cardiomyocytes; B, skeletal
myotubes), smooth muscles (C, empty arrows in duodenum), and fibroblasts of dermal papilla (D, solid arrows) have strong MECP2 signal in
both species. Similarly, gastrodermal epithelial cells (empty arrowheads) and matrix keratinocytes (solid arrowheads) lack MECP2 in both species.
Single confocal sections. Scale bars: (A) 5 μm, (B, D) 10 μm, (C) 25 μm.
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that simultaneous deficiency of three methyl-CpG binding
proteins MECP2, MBD2, and KAISO in mice is compat-
ible with normal embryogenesis and provided evidence
for redundancy of function between these proteins in
postnatal mice. Since antibodies to other methyl-CpG
binding proteins reliably working on cryosections are
lacking, we quantitatively studied the expression level
of all known 5mC-binding proteins in Mecp2−/y cultured
cells and tissues by reverse transcription quantitative poly-
merase chain reaction (RT-qPCR). We focused on an
expression analysis of the following methyl binding pro-
teins: four MBD proteins, MBD1, MBD2, MBD3, and
MBD6 (MBD4 and MBD5 were omitted due to the nearly
undetectable expression level); UHRF1 and UHRF2;
SETDB1; and three methyl-CpG binding zinc finger
proteins, namely, ZBTB33, ZBTB38, and ZBTB4. First,
we analyzed the expression of all the above genes in
adult Mecp2−/y, adult Mecp2lox/y, and embryonic wild-
type fibroblasts. The analyzed genes were transcribed at
different levels in embryonic and adult fibroblasts. In
particular, we noted a statistically significant decrease in the
expression of Mbd1 and Mbd6, Uhrf1 and Uhrf2, Zbtb33
and Zbtb4, and Setdb1 in the embryonic fibroblasts
compared to the adult cultured fibroblasts. However, we
found no apparent difference in gene expression between
the adult Mecp2lox/y and Mecp2−/y fibroblasts (Figure 8A).
Similarly, comparison of gene expression in the skeletal
muscle, heart, and small intestine did not reveal any differ-
ences between tissues from Mecp2−/y and Mecp2wt mice
(Additional file 6). Unexpectedly, in the Mecp2−/y brain
and liver, the expression of these proteins (e.g., MBD2)
was even significantly decreased (Figure 8B,C). Thus, we
demonstrated that absence of MECP2 is not compensated
by any other known 5mC binding protein at least at the
mRNA level.Conclusions
Based on the above discussion, the following conclusions
were made:
 All retinal neurons, except rods, express MECP2 at
a high level and the onset of its expression coincides
with neuron differentiation, in particular, with
massive formation of neural synapses in the inner
and outer plexiform layers.
 Low expression of MECP2 in rod photoreceptors
was found in both the inverted rod nuclei of
nocturnal mammals and the conventional rod nuclei
of diurnal mammals. We relate this fact to an
unusually high level of histone H1c in these cells in
comparison to other retinal neurons [43].
 MECP2 is not detectable by immunostaining in the
retinal microglial cells, nor in the microglia of the
cortex, cerebellum, and spinal cord. In contrast to
microglia, the astroglial cells in all neuronal tissues
express MECP2 at a level comparable to that in
neurons.
 The retina of Mecp2-null mice shows no apparent
defects in the timing and morphology of the nuclear
and plexiform layer formation. No noticeable
difference in the distribution of certain neuron
types, synapses, and neurotransmitters was found
between Mecp2-null and wild-type retinas.
 The nuclear architecture of the neuroretinal cells
and rod photoreceptors is generally preserved in
Mecp2-null mice; in particular, there are no obvious
changes in the distribution of pericentromeric
heterochromatin and major epigenetic markers
characteristic for eu- and heterochromatin.
 MECP2 is expressed in the majority of studied 64
non-neuronal cell types; cells which do not express
MECP2 are epithelial cells of the intestine, cells of
Figure 6 Expression of MECP2 during development and terminal cell differentiation. (A) The onset of MECP2 expression (green) in different
cell types of mouse retina. Time lines are shown for pigment epithelial cells (PEC), ganglion cells (GC), amacrine cells (AC), horizontal cells (HC), bipolar
cells (BC), cone photoreceptor (CP), and rod photoreceptor (RP). On the left, postnatal age points are shown; numbers below the time lines show
the cell birthdays (the day of the last cell division; [60]). Grey horizontal lines mark age points when the outer and inner plexiform layers (OPL and IPL,
respectively) become detectable (see also [57-59]). Light green marks a low MECP2 level. The onset of MECP2 expression in neurons coincides with
massive formation of synapses and, consequently, IPL and OPL plexi. (B) Arrangement of the nuclear and plexiform layers in mouse retina revealed
in a paraffin section after hemalaun-eosin staining and in a cryosection after nuclear counterstain with DAPI. The perikarya of GCs are located in the
GCL; those of BCs, ACs, and HCs are in the INL; and those of the photoreceptors are in the ONL. (C) Examples of retinal cells (marked by arrows) with
initiated MECP2 expression at three age stages. Single and double asterisks mark OPL and IPL, respectively; the abbreviations are the same as in (A). For
comparison with adult mouse retina, see Figure 1A. (D) In the fibroblasts of the dermal papilla (arrowheads) of the hair follicle, MECP2 expression is
initiated postnatally and becomes detectable at P2; later, the MECP2 expression in these cells remains stably high (see also Figure 4A,D). (C, D) Single
confocal sections. Scale bars: (B) 10 μm; (C) overviews 50 μm, close-ups 10 μm; (D) 25 μm.
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and mature gonads; epidermis keratinocytes express
MECP2 at a very low level.
 Similarly to neurons, the expression of MECP2 in
non-neuronal cells is initiated at the late differentiation
stages; in this respect, gonads show a reverse patternwith no expression in differentiated oocytes and
spermatozoids.
 An absence of MECP2 is not compensated by
increased expression of other methyl binding
proteins; in contrast, expression of some of them
was downregulated.
Figure 7 Expression of MECP2 in the ovary (A) and testis (B). Only young oocytes (A1, arrows) express MECP2; the more mature oocytes
(A2) do not express MECP2 (A2, empty arrow). Neighboring follicular cells (arrowheads) strongly express MECP2. In testis, only Sertoli cells
(B2, arrowhead) and fibroblasts (B2, arrows) express MECP2; spermatocytes at all stages of maturation and sperm cells are MECP2-negative.
Single confocal sections. Scale bars: (A1, A2) 25 μm, (B1) 50 μm, (B2) 10 μm.
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Animals and primary cell cultures
All procedures were approved by the Animal Ethic
Committee of Munich University and Edinburgh Univer-
sity. CD1, C57Bl/6, and Mecp2-null mice were killed by
cervical dislocation according to the standard protocol.
Mecp2−/y mice (described in [9]; Jackson Laboratory stock
number: 003890) were generated along with wild-type
littermates by crossing Mecp2+/− females with wild-type
male mice. The generation of mice ectopically expressing
LBR in rod cells under the control of the Nrl promoter is
described in [41]. Retinas of R7E mice [42] were studied at
the age of 70 weeks. Retinas from mice with combined
deletions of Suv3-9 and Suv4-20 were a kind gift from
G. Schotta (University of Munich). Wild-type littermate
controls for all genetically modified mice were studied
in parallel. Tail fibroblast cell lines from Mecp2−/y and
Mecp2lox/y mice are described in [9].
Tissues, fixation, and cryosections
The retinas of the ICR/CD1 mice were studied on each
day between E12 and P28. The retinas of Mecp2−/y mice
and their WT littermates were studied at the ages of P1,
P7, P14, P30, and P53. Retina fixation, embedding in
freezing medium, and preparation of cryosections were
performed as described previously [38,39]. Briefly, the
eyes were enucleated immediately after death; the ret-
inas were dissected and fixed with 4% formaldehyde in
phosphate-buffered saline (PBS) for various times (15 min,
30 min, 1 h, 3 h, and 24 h). After washing in PBS, the sam-
ples were infiltrated in 10%, 20%, and 30% sucrose in PBS
before freezing in Jung freezing medium. Importantly,
the retina samples at different ages, from WT and trans-
genic mice, and of various fixation times, were arranged in
respective order in the same block to assure identification
of all retina samples in a section [39]. Retinas frommonkey (Macaca fascicularis) and rat (Rattus norvegicus)
were post mortem experimental materials from the MPI
for Brain Research (Frankfurt, Germany). Other tissue
samples from adult C57Bl/6 mice and rats were fixed
with 4% formaldehyde in PBS for 24 h. For some tis-
sues, the samples from different developmental stages –
P0, P2, P5, P9, P14, and P28 – were used.
Immunostaining on cryosections
Immunostaining was performed according to the protocol
described in detail by [38,39]. This protocol allows quick
testing of a wide range of fixation and antigen retrieval
times and detection of the range in which the results of
staining are robust. Antigen retrieval was crucial for
robust MECP2 staining and was performed by heating
cryosections in 10 mM sodium citrate buffer at 80°C.
MECP2 detection after 12–24 h of tissue fixation was
most successful after 20–30 min of antigen retrieval.
For MECP2 immunostaining, mostly rabbit polyclonal
antibodies were used. Specificity of the antibody was
checked using fibroblasts derived from Mecp2−/y and
Mecp2lox/y mice (Additional file 1). In some cases, rat
monoclonal antibodies were used as well [65]. The anti-
bodies for cell type identification and for recognition of
retinal structures are listed in Tables 1 and 3. Antibodies
for the detection of histone modifications are listed in
Table 2. Secondary antibodies were anti-mouse IgG
conjugated to Alexa555 (A31570, Invitrogen, Renfrew,
UK) or Alexa488 (A21202, Invitrogen), and anti-rabbit
IgG conjugated to DyLight549 (711-505-152, Jackson
ImmunoResearch, West Grove, PA, USA) or DyLight488
(711-485-152, Jackson ImmunoResearch). The nuclei were
counterstained with DAPI added to the secondary anti-
body solution. After staining, the sections were mounted
under a coverslip with Vectashield (Vector Laboratories,
Inc., Burlingame, CA, USA).
Figure 8 Analysis of expression of MBD proteins in cultured fibroblasts and tissues from Mecp2−/y and wild-type mice. (A) Relative
transcription level of MBD proteins in wild-type embryonic fibroblasts (MEF W9) and adult fibroblasts established from Mecp2−/y and littermate
Mecp2lox/y mice. Values are normalized to the Mecp2 transcript in the embryonic fibroblasts. Note that the mRNA levels in the embryonic and
adult fibroblasts differ, whereas no difference in transcription was detected between Mecp2−/y and Mecp2lox/y genotypes. Relative transcription
level of MBD proteins in the brain (B) and liver (C) from Mecp2−/y and littermate Mecp2wt mice. Values are normalized to the Mecp2 transcript in
the respective Mecp2wt tissue. Note that there is no upregulation of MBD protein genes upon deletion of Mecp2. Results of real-time PCR analysis
of two (for tissues) and three (for cells) biological replicates are given as mean ± S.E.M. Statistical difference between values was estimated by t
test; statistically significant differences in transcription levels are marked by asterisks (*<0.05; **<0.01).
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Single optical sections or stacks of optical sections
were collected using a Leica TCS SP5 confocal micro-
scope (Milton Keynes, UK) equipped with Plan Apo
63×/1.4 NA oil immersion objective and lasers withexcitation lines 405, 488, and 561 nm. Dedicated plug-
ins in the ImageJ program were used to compensate
for axial chromatic shift between fluorochromes in
confocal stacks, to create RGB stacks/images, and to
arrange optical sections into galleries [66,67].
Table 4 List of primers used for real-time PCR
Gene Forward Reverse
Mbd1* GAGCACAGAGAATCGCCTTC CACACCCCACAGTCCTCTTT
Mbd2* CTGGCAAGATACCTGGGAAA TTCCGGAGTCTCTGCTTGTT
Mbd3* AGAAGAACCCTGGTGTGTGG TGTACCAGCTCCTCCTGCTT
Mbd4* ACAGGATGGCTCTGAAATGC TCTACTTGTGTCCGTGGGATG
Mbd5 isoform 1** GAGGCCATGAGCGAACTG TCTTCCTCCTCTTGGGTTTG
Mbd6** CCCGGGGATAGTCAGAAAGT AGCTGCTCGCGTTGTAGG
Mecp2* CAGGCAAAGCAGAAACATCA GCAAGGTGGGGTCATCATAC
Zbtb33 ATCATTAGCTCCAGTCCAGACTCA ATCTGCATCTTCTGTGTCAATGATC
Zbtb38* CATCTTTTGGAGCCATACGATCT TGACGGTTTCCTGTCTTTTGAC
Zbtb4 CCCTGCCGCTACTGTGAGA CAGCAGAAGATGCACTGGTACCT
Setdb1 GGCCATTCCTCCCCTACTTC GGCCAAAGGTGACCGATATG
Uhrf1 GGCAGCTGAAGCGGATGA CCATGCACCGAAGATATTGTCA
Uhrf2UHRF2 CATGGTCGCAGCAATGATG CACCGCTTCCAGTATACGTGAA
Gapdh CATGGCCTTCCGTGTTCCTA CTTCACCACCTTCTTGATGTCATC
Single asterisk denotes that the sequence was taken from [64]. Double asterisks signify that the sequence was taken from [69].
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Chromocenters in the rod cells were scored at two age
points, P30 and P53. For each age, three mice were used,
two Mecp2−/y and one Mecp2+/y littermate. From each
animal 25-μm-thick cryosections were prepared from
the three retina areas: central, mid, and peripheral. To
distinguish between individual nuclei in tightly packed
rod perikarya, the nuclear envelope of rod cells was
stained with anti-lamin B1 antibodies (sc-6217). Between
600 and 800 rod cell nuclei were scored in stacks
collected from each retina area. Descriptive statistics was
performed using SigmaStat software.RNA isolation and RT-qPCR
The tissue samples of Mecp2-null mice were collected
in ‘RNAlater’ (Qiagen, Venlo, Netherlands) and stored
at −20°C. Isolation of RNA and reverse transcription
were carried out as described previously [68]. Primers
for RT-qPCR were either designed with the Primer
Express software (Applied Biosystems Inc., Foster City,
CA, USA) or used as previously published (Table 4).
RT-qPCR was performed on the 7500 Fast Real-Time
PCR System (Applied Biosystems) at standard reaction
conditions using the Power SYBR Green PCR Master
Mix (Applied Biosystems). Gene expression levels were
normalized to Gapdh and calculated using the compara-
tive CT method (ΔΔCT method). Relative quantification
of gene expression was performed by the 2−ΔΔCT method
based on the CT values of both target and reference
genes. The results of the real-time PCR analysis of two
(tissues) and three (cells) biological replicates are given
as mean ± S.E.M. The statistical difference between the
values was estimated by t test using SSPS.Additional files
Additional file 1: Immunostaining and Western blot analysis with
rabbit anti-MECP2 antibody. Specificity of the rabbit anti-MECP2
antibody and its application for Western blot analysis of MECP2 level in
different mouse tissues.
Additional file 2: Mecp2−/y and Mecp2wt retinas at different
developmental stages. Mecp2−/y and Mecp2wt littermate retinas are not
different with respect to the time of layer formation, thickness of nuclear and
plexiform layers, and other morphological features.
Additional file 3: Distribution of neurons, synapses, and
neurotransmitters in Mecp2wt and Mecp2−/y retinas. Retinas of Mecp2−/y
mice show no apparent defects in the distribution of neurons, synapses, and
neurotransmitters in comparison to Mecp2wt littermates.
Additional file 4: Distribution of histone modifications in ganglion
and INL cells of Mecp2wt and Mecp2−/y retinas. Similar distribution of
histone modifications characteristic of euchromatin and heterochromatin
in Mecp2−/y and Mecp2wt mice.
Additional file 5: MECP2 expression in retinal cells from Suv3-9/
Suv4-20 double KO mice. Similar to WT mouse retina, rods of double
KO mice express MECP2 at a very low level, whereas other retinal
neurons strongly express MECP2.
Additional file 6: Gene expression analysis of MBD proteins in
Mecp2−/y and wild-type mice. Relative transcription levels of MBD
proteins were determined by RT-qPCR in gut, skeletal muscles and heart
of Mecp2−/y and Mecp2wt mice.
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